Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Leuk Lymphoma. 2013 Aug 13;55(3):624–627. doi: 10.3109/10428194.2013.820293

Figure 2.

Figure 2

Flow cytometry analysis of CD30 expression in 5 patients with persistent precursor T-lymphoblastic leukemia (T-ALL) after receiving intense chemotherapy. Follow-up bone marrow samples were collected in a median interval of 2 months (1–7 months), CD30 expression is upregulated in all 5 patients (p=0.025).